i think there might be tax benefits in the transfer of shares,but a 30/1 ratio you've used as an example, would'nt even be considered by the board...let alone submitted to the shareholders...i understand this ratio has been determined by a likely market premium....but in my view ,not relevant in this imaginary scenario.10/1...may be a starting point....that's only 3% dilution for novartis shareholders....a cheap price for all those patents owned by MSB.(...but hey...all just huff and puff)....
i think there might be tax benefits in the transfer of...
-
- There are more pages in this discussion • 9,454 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.0¢ |
Change
-0.025(2.51%) |
Mkt cap ! $1.138B | |||
| Open | High | Low | Value | Volume |
| 99.0¢ | $1.03 | 97.0¢ | $2.815M | 2.838M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 151781 | 97.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 97.5¢ | 80522 | 1 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |